logo
2nd World Congress on
Cancer Science & Therapy
September 10-12, 2012 Hilton San Antonio Airport, USA
 
Cancer Science-2012

    Previous Events
     
     
    Participants List in Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    University Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    University di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-University Halle-Wittenberg, USA

    University de Sao Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    University Paris 13, France

     
    Participants List From Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Womens Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddys labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


     
    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
      Day 3
    Scientific Program
    2nd World Congress on Cancer Science & Therapy, will be organized around the theme "Emerging Trends in Cancer Science and Therapy."

    Cancer Science-2012 is comprised of 11 tracks and 69 sessions designed to offer comprehensive sessions that address current issues in Cancer Science & Therapy.

    Submit your abstract to any of the following tracks. All related abstracts are accepted.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Track 1: Cancer Cell Biology
    Track 1-1 Cancer stem cells and metastatic growth
    Track 1-2 Cell to cell signaling and membrane proteins
    Track 1-3 Inflammation and inflammatory factors in cancer development
    Track 1-4 Metastatic cell growth and adhesion, apoptosis and cell division
    Track 1-5 Cancer biology
    Track 1-6 Tumor virology and pathology
    Track 1-7 Cancer systems biology
    Track 2: Diagnostic and Prognostic Cancer Biomarkers
    Track 2-1 Biomarkers in cancer therapy and molecular diagnostics
    Track 2-2 Genetic and DNA methylation-based biomarkers
    Track 2-3 Prognostic biomarkers
    Track 2-4 Biomarkers based on cancer types
    Track 2-5 Biomarkers for cancer cell process
    Track 2-6 Biomarkers for pathogenic process
    Track 2-7 Biomarkers for pharmacologic responses
    Track 3: Advances in Cancer Detection and Imaging
    Track 3-1 Fluorescence imaging techniques
    Track 3-2 Digital mammography and computer-aided detection system
    Track 3-3 Electrical impedance scanning
    Track 3-4 Nanotechnology based detection
    Track 3-5 Tumor microarrays
    Track 4: Cancer: Management & Prevention
    Track 4-1 Diet and physical exercise
    Track 4-2 Chemoprevention
    Track 4-3 Cancer epidemiology and prevention
    Track 4-4 DNA damage and repair
    Track 5: Cancer Therapy
    Track 5-1 Radiotherapy and chemotherapy
    Track 5-2 Gene therapy and tumor immunity
    Track 5-3 Hormone replacement therapy
    Track 5-4 Molecular-targeted therapies
    Track 5-5 Cancer: gene expression and protein profiling, surgery and laparoscopy
    Track 5-6 Stem cells and cancer cell therapy
    Track 5-7 Senescence induction
    Track 5-8 Bacterial treatment
    Track 5-9 Telomerase therapy
    Track 5-10 Drug therapies
    Track 6: Clinical Cancer Research
    Track 6-1 Clinical medicine
    Track 6-2 Targeting anticancer drugs
    Track 6-3 Therapeutic targets in cancer
    Track 6-4 Clinical research in cancer immunology
    Track 6-5 Nanotechnology and novel drug delivery systems
    Track 6-6 Therapeutic cancer vaccines
    Track 6-7 Antioxidants as cancer preventive agent
    Track 7: Carcinogenesis and Mutagenesis
    Track 7-1 Metabolism of carcinogens
    Track 7-2 Identification and detection of carcinogens
    Track 7-3 Biological and external factors for carcinogenesis
    Track 7-4 Mutagenesis- directed, site-specific and mismatched
    Track 7-5 Environmental mutagenesis
    Track 8: OMICS in Cancer Research
    Track 8-1 High-throughput DNA sequencing technologies
    Track 8-2 Operomics
    Track 8-3 Bioinformatics
    Track 8-4 Viral oncoproteomics
    Track 9: Organ-Specific Cancers
    Track 9-1 Head and brain cancer
    Track 9-2 Nasopharyngeal, oral cavity, and thyroid cancers
    Track 9-3 Neck, breast cancer, ovarian, and cervical cancer
    Track 9-4 Oesophageal and gastrointestinal cancers
    Track 9-5 Rectum, liver, cholecyst, and pancreatic cancer
    Track 9-6 Bone,Leukemia, and myelodysplasia
    Track 9-7 Lymphoma, melanoma skin cancer, and sarcomas
    Track 9-8 Lung and prostate cancer
    Track 9-9 Colorectal or colon cancers
    Track 9-10 Urology, kidney/renal cancers
    Track 9-11 Pediatric oncology
    Track 10: Cancer Genetics
    Track 10-1 Oncogenes
    Track 10-2 Tumour suppressor genes
    Track 10-3 Viruses and human cancer
    Track 10-4 Genetics and toxicity
    Track 10-5 Gene silencing and genome imprinting
    Track 10-6 Gene silencing and RNA interference
    Track 10-7 Non-coding RNA in cancer
    Track 10-8 DNA sequencing in cancerous cells
    Track 11: Overcoming Inequalities in Cancer Patients- A Case Study
    Track 11-1 Cancer research: Clinical and experimental
     
     
    FIND US ON
    Conference Secretariat: Cancer Science-2012, OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Phone: +1-650-268-9744 l Fax: +1-650-618-1414
    Toll free: 1-800-216-6499 (USA & Canada) l 1-800-651-097 (Australia) l 0805-080048 (Europe)
    E-mail: cancerscience2012@omicsonline.com
    Operated by : Editors - Journal of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis
    and Chemotherapy: Open Access
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version